Results 111 to 120 of about 25,606 (215)

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection

, 1989
Zidovudine pharmacokinetics were determined in 16 children with human immunodeficiency virus infection who were being treated intravenously and orally on an intermittent schedule (every 6 hours).
Jarosinski, Paul F, Balis, Frank M, Pizzo, Phillip A, Eddy, Janie, Scott, Gwendolyn, Wilfert, Cathy, Murphy, Robert F, McKinney, Ross, Falloon, Judy, Poplack, David G   +9 more
core   +1 more source

ZIDOVUDINE: A TARGETED THERAPY FOR ENDEMIC BURKITT'S LYMPHOMA

, 2011
Background: Although cyclophosphamide based regimens can produce remission rates approaching 60 to 80% in endemic Burkitts lymphoma, relapses and refractory disease are fairly common in developing countries, due to advanced stage disease and ...
HARRINGTON, W.J., KUROKAWA, M., ANDELA, V., GHOSH, S., BARRETO, J. E.   +4 more
core  

Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people

, 1996
We studied 14 zidovudine-naive, HIV-1-infected patients attending an infectious diseases clinic in Milan during zidovudine therapy for 6 months. We monitored CD4 cell counts, immune complex-dissociated p24 antigen, viral phenotype and viral load in ...
M. Moroni, S. Kurtagic, F. Mainini, N. Zanchetta, M. P. De Pasquale, S. Rusconi, M. Galli, A. Gori, M. Violin, C. Balotta, E. Bulgheroni   +10 more
core  

Zidovudine plus didanosine in primary HIV-1 infection

, 1997
Viraemia levels in the months following primary HIV-1 infection (PHI) predict the subsequent course of the infection. Inhibition of viral replication in PHI patients might improve their clinical prognosis.
Charvier, A., Hirschel, Bernard, Yerly Ferrillo, Sabine, Schockmel, G. A., Figueras, G., Perrin, Luc   +5 more
core  

Zidovudine in persons with asympomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter [PDF]

, 1993
Bogner, Johannes R., Cooper, David A., Stevens, John W., Stingl, Georg, Melville, Rex L., Millard, Judith, Bruun, Johan N., Gonzalez-Lahoz, Juan, Kroon, Susanne, Clumeck, Nathan, Goebel, Frank-Detlef, Mertins, P., Gatell, Jose M., Goos, M., Jänike, F., Fiddian, A. Paul   +15 more
core  

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj  

Neonatal Lactic Acidosis Associated With Antiretroviral Exposure: A Case Report. [PDF]

Cureus
Mercado J, Rivera L, Droz López A, Poventud Y, Andino-Colón C.   +4 more
europepmc   +1 more source

Preparation and Evaluation of Modified Release Zidovudine Tablets

, 2015
Zidovudine is a drug used for the treatment of AIDS. The objective of this work was to prepare tablets for modified release of zidovudine. Hydroxypropyl methylcellulose HPMC K100LV and HPMC K4M at 1250 %, 18.75 % and 25.00 % were used.
Bicheri, MTL, Chaud, MV, Goncalves, MM, Vila, MMDC   +3 more
core  

Bibliometric review of worldwide scientific literature on mother-to-child transmission of HIV (1980-2023). [PDF]

Medicine (Baltimore)
Karasneh RA, Al-Azzam SI, Alzoubi KH, Zyoud SH, Sweileh WM.   +4 more
europepmc   +1 more source

Preventing Mother to Child Transmission of Human Immunodeficiency Virus: 20-Year Trends in Management and Clinical Practice in a French Hospital - A Retrospective Observational Study. [PDF]

Health Sci Rep
Dmitrenko B, Vintejoux E, Fuchs F, Pissarra J, Moulis L, Van de Perre P.   +5 more
europepmc   +1 more source